World Heart Federation: Tobacco is Responsible For More Than One in Ten Deaths Caused by Cardiovascular Disease

Food and Healthcare Press Releases Wednesday May 30, 2018 08:30
GENEVA--30 May--PRNewswire/InfoQuest
  • The theme of WHO World No Tobacco Day 2018 on 31 May is: "Tobacco breaks hearts, choose health and not tobacco"
  • Smoking is associated with around 7 million global deaths per year and is an independent, major risk factor for myocardial infarction, stroke, heart failure and low quality of life
  • The World Heart Federation is working with the WHO on the occasion of World No Tobacco Day to raise awareness of the link between tobacco and CVD, and to promote the immediate and long-term benefits of stopping smoking

World No Tobacco Day is a World Health Organization initiative that will be held on 31 May and this year will focus on raising awareness of the link between tobacco and cardiovascular disease (CVD). Tobacco is associated with around 7 million deaths worldwide every year, directly related to the consumption of and indirect exposure to smoke.

(Logo: https://mma.prnewswire.com/media/696965/World_Heart_Federation_Logo.jpg )

Smoking damages blood vessels and thickens blood. It increases blood rate and blood pressure and replaces oxygen, making it an important risk factor in the development of coronary disease, stroke and peripheral vascular disease. Furthermore, it is the second most prevalent cause of CVD after hypertension. Given that CVDs constitute the number one cause of death in the world, the World Heart Federation (WHF) applauds this initiative by the World Health Organization (WHO).

Despite the general public being familiar with the impact that tobacco causes on health, the WHO highlights the fact that it is rarely thought of as being one of the main causes for CVD. According to WHF President Professor David Wood: "Tobacco consumption constitutes the main avoidable risk for cardiovascular health. Because of this, it is our duty to help our patients with heart disease to quit smoking, and for those patients at high risk of having a heart attack or stroke to help them quit as well. By doing so we can help all our patients to reduce their risk but even more importantly we need to raise awareness and educate the general public about the impact tobacco on our hearts and crucially the importance of children and young people never starting."

Almost 80% of the one billion smokers around the world live in average and lower income countries where the burden of illness and death associated with tobacco is much greater. With this in mind, WHF through its "Because every heartbeat matters" policy is promoting an agenda of greater access to care and the prevention, control and management of cardiovascular illnesses for everyone, regardless of status or circumstance, with the objective of extending and improving quality of life.

"We firmly believe in the need to continually highlight the risks of tobacco to the health of our hearts and circulation. By bringing together healthcare professionals, governments, institutions, industry and the general public around a common cause we can continue to educate people about the dangers of tobacco and unhealthy lifestyles, and promote the need for universal access to care," adds Prof. Wood. To aid this education, WHF will soon be releasing two fact sheets on smoking cessation: one for the general public and one for professionals.

On 29 September, WHF will be celebrating World Heart Day with the objective of raising awareness about the importance of good cardiovascular health. One of their key messages is around the immediate and long-term health benefits brought about by quitting smoking:

  • Within just 20 minutes, heart rate and blood pressure drops
  • 12 hours after stopping smoking, the carbon monoxide levels in blood drops and returns to normal levels
  • Between 2 and 12 weeks, circulation will have improved and pulmonary function increased
  • Over the first 9 months, coughing and breathlessness diminishes
  • One year after quitting smoking, the risk of contracting a coronary disease is approximately half that of a smoker
  • Between 5 and 15 years after quitting smoking, the risk of suffering from a cerebrovascular accident drops to that of a non-smoker
  • 15 years after having quit smoking, the risk of suffering from a coronary disease equates to that of a non-smoker
Source: World Heart Federation

Latest Press Release

Walgreens Boots Alliance and Microsoft establish strategic partnership to transform health care delivery

- Companies aim to improve health outcomes and lower overall costs with enhanced digital and retail experiences and an R&D commitment to build health care solutions through seven-year agreement Walgreens Boots Alliance Inc. (WBA) and Microsoft Corp....

Ascensia Diabetes Care Announces Global Partnership With POCTech to Distribute and Co-develop Continuous Glucose Monitoring Systems

Ascensia Diabetes Care today announced it has entered into a global alliance with Zhejiang POCTech, Co., Ltd (POCTech), a developer and manufacturer of continuous glucose monitoring (CGM) systems. (Logo:...

MGI Announces Milestone of 1,000 Sequencers Installed and Opens Early Access Program for Groundbreaking Ultra-High-Throughput Sequencer, MGISEQ-T7

MGI, established in 2016 as a subsidiary of global genomics leader BGI Group, announced it has reached a new milestone of 1,000 MGI sequencers installed in 16 countries. MGI Chief Operating Officer Dr. Hui Jiang also announced the availability of MGI's...

Gift of Life Donor Program is U.S. Leader in Saving Lives

For the 11th consecutive year, Gift of Life Donor Program is the nation's leading organ procurement organization (OPO), coordinating the most life-saving organs for transplant among all 58 U.S. OPOs. Gift of Life broke two national records in 2018,...

Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat

Licensing rights are worldwide excluding US, Canada, Japan and South AmericaHelsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and Menarini, an Italian biopharmaceutical Group active in 136 countries worldwide, today...

Related Topics